Neurology Devices Market Report 2025

The neurology devices market size has grown rapidly in recent years. It will grow from $18.42 billion in 2024 to $20.79 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to rapid growth in elderly population, rapid technology advances, economic growth in emerging markets, increase in R&D in the field and huge investments by private players in neurology devices.

The neurology devices market size is expected to see rapid growth in the next few years. It will grow to $33.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing elderly population, changes in lifestyle, rising awareness of neurological disorders, rise in burden of neurological diseases, faster economic growth. Major trends in the forecast period include investing in developing neuromodulation devices, wearable neurology devices, new product launches, adopting mergers and acquisition strategies and increasing research and development activities.

The demand for neurology devices is anticipated to witness growth driven by favorable government initiatives. Government initiatives aimed at overseeing and promoting the safety, quality, and advancement of medical devices can significantly impact the neurology device market. These initiatives may include policies, regulations, and programs that influence various aspects of the market, such as research and development funding, financial incentives, regulations, telemedicine expansion, public health awareness, and overall healthcare infrastructure improvement. A notable example is the Food and Drug Administration (FDA) in the US, which extended the Total Product Life Cycle Advisory Program (TAP) to cover neurological and physical medicine devices, with a focus on accelerating technological advancements in these areas. The expansion of such programs by regulatory bodies is expected to stimulate the growth of the neurology device market.

The expanding patient population due to the global rise in the elderly demographic significantly boosted the neurology devices market during the historic period. Neurology devices, such as MRI and CT scanners, play a crucial role in diagnosing age-related neurological conditions, including Alzheimer's disease, Parkinson's disease, and strokes. According to a January 2024 report by the US-based Pew Research Center, the geriatric population, which was 0.2% in 2024, is expected to grow to 0.5% by 2054. These trends have driven demand for neurology devices, fueling market growth during the historic period.

Major players in the neurology devices market are focusing on the development of digital platforms to enhance their product offerings and improve patient treatment. Platforms such as BrainTale-care are dedicated to monitoring and predicting neurological disorders, providing valuable decision support for medical professionals. For example, Braintale, a France-based medical device company, introduced the brainTale-care platform featuring modules such as brainQuant for white matter quantification and brainScore-coma for coma recovery prediction. This advancement aims to provide clinicians with innovative digital medical devices for enhanced diagnosis, monitoring, and prediction of neurological disease progression.

Leading companies in the neurology devices market are advancing implantable wireless brain devices, transforming neurological treatment through real-time monitoring and brain-computer interfaces. These innovations emphasize minimally invasive techniques, improved patient outcomes, and personalized therapies. Advanced medical devices are sophisticated tools employing cutting-edge technology for diagnosis, therapy, or monitoring. For instance, in April 2024, Medtronic, an Ireland-based medical device company, introduced the NeuroSmart Portable Micro Electrode Recording (MER) Navigation System. This system enhances Deep Brain Stimulation (DBS) procedures for Parkinson's disease by enabling real-time, precise electrode placement with automatic navigation, resulting in improved patient outcomes and fewer side effects. Its portability and advanced features allow clinicians to deliver tailored treatments efficiently.

Major companies operating in the neurology devices market include Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Integra LifeSciences, Abbott Laboratories, Terumo Corporation, LivaNova, PLC, Integer, Penumbra, Inc., B. Braun Group, Johnson & Johnson, W.L Gore, St. Jude Medical LLC, Parasym, TUR Therapietechnik GmbH, Smiths Medical, Cizeta Surgical, Neuro France Implants, Ectron, Accentus Medical Ltd, Adaptix, Argonaut Therapeutics, Brainwave Discovery, Cerus Endovascular, Chronus Therapeutics, Natus Medical Incorporated, Cerenovus, Nevro, Aleva Neurotherapeutics SA, Dynatronics Corporation, Cyberonics Inc.

North America was the largest region in the global neurology devices market in 2024. Asia-Pacific was the second largest region in the global neurology devices market. Africa was the smallest region in the global neurology devices market. The regions covered in the neurology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurology devices market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The neurology devices market consists of sales of neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices that are used to treat neurological disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Neurology devices are employed for the diagnosis, prevention, and treatment of various neurological disorders, including Alzheimer's, spinal cord injury, traumatic brain injury, and conditions affecting hearing and sight for patients with limb loss or congenital limb differences.

The primary types of neurology devices include cerebrospinal fluid management (CSF) devices and equipment, interventional neurology devices and equipment, neurosurgery devices and equipment, and neurostimulation devices. Neurostimulation devices generate electrical impulses placed under the patient's skin in specific parts of the body. Expenditures for these devices come from both public and private sources. The products encompass Instruments Or Equipment and disposables. Various end-users, including hospitals, clinics, diagnostic laboratories, and others, are involved in the use of neurology devices.

The neurology devices market research report is one of a series of new reports that provides neurology devices market statistics, including neurology devices industry global market size, regional shares, competitors with a neurology devices market share, detailed neurology devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurology devices industry. This neurology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.